A5050819548- Immune cells in cancer
- Glioma Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- Neuroinflammation and Neurodegeneration Mechanisms
- Nuclear Receptors and Signaling
- Ferroptosis and cancer prognosis
Southern Medical University
2023
Guangdong Provincial People's Hospital
2023
Guangdong Academy of Medical Sciences
2023
Affiliated Eye Hospital of Wenzhou Medical College
2021
Wenzhou Medical University
2021
Abstract Glioblastoma (GBM) is the deadliest form of brain cancer. It a highly angiogenic and immunosuppressive malignancy. Although immune checkpoint blockade therapies have revolutionized treatment for many types cancer, their therapeutic efficacy in GBM has been far less than expected or even ineffective. In this study, we found that genomic signature glioma-derived endothelial cells (GdEC) correlates with an state poor prognosis patients glioma. We established vitro model GdEC...
<div>Abstract<p>Glioblastoma (GBM) is the deadliest form of brain cancer, characterized as a highly angiogenetic and immunosuppressive malignancy. Although immune checkpoint blockades have revolutionized cancer therapy, their therapeutic efficacy in GBM has been far less than expected or even ineffective. Here, we reveal that genomic signature glioma-derived endothelial cells (GdECs) correlates with an state poor prognosis glioma patients. In vitro model GdECs differentiation...
<p>Supplementary Figure 1-12</p>
<p>Supplementary Figure 1-12</p>
<p>Supplementary Figure 1-12</p>
<div>Abstract<p>Glioblastoma (GBM) is the deadliest form of brain cancer. It a highly angiogenic and immunosuppressive malignancy. Although immune checkpoint blockade therapies have revolutionized treatment for many types cancer, their therapeutic efficacy in GBM has been far less than expected or even ineffective. In this study, we found that genomic signature glioma-derived endothelial cells (GdEC) correlates with an state poor prognosis patients glioma. We established...
<div>Abstract<p>Glioblastoma (GBM) is the deadliest form of brain cancer. It a highly angiogenic and immunosuppressive malignancy. Although immune checkpoint blockade therapies have revolutionized treatment for many types cancer, their therapeutic efficacy in GBM has been far less than expected or even ineffective. In this study, we found that genomic signature glioma-derived endothelial cells (GdEC) correlates with an state poor prognosis patients glioma. We established...
<p>Supplementary Figure 1-12</p>